CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported a loss of $40.1 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 27 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
